injection tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide for Rapid and Sustainable

And the safety profile and discontinuation rates are consistent with other established members of the broadening class of GLP-1 medicines, which is reassuring, says Drucker, who has previously consulted for Eli Lilly but was also not involved in the trial

For patients using tirzepatide for type 2 diabetes management, worsening glycemic control despite consistent medication use requires prompt evaluation

These approvals marked significant shifts in obesity medicine, with clinical trials demonstrating 15-22% body weight reduction over 68 weeks

Adding the glucagon pathway is what sets retatrutide apart

These medications help reduce appetite, stabilize blood sugar, and promote meaningful weight loss often when diet and exercise alone have not been enough